<scp>iGlarLixi</scp> versus basal plus <scp>Rapid‐Acting</scp> insulin in adults with type 2 diabetes advancing from basal insulin therapy: The <scp>SoliSimplify Real‐World</scp> study - Concepedia

Concepedia

Publication | Open Access

<scp>iGlarLixi</scp> versus basal plus <scp>Rapid‐Acting</scp> insulin in adults with type 2 diabetes advancing from basal insulin therapy: The <scp>SoliSimplify Real‐World</scp> study

DOI Full Paper Access

16

Citations

22

References

2022

Year

Rory J. McCrimmon, Alice Cheng, G. R. Galstyan, Khier Djaballah, Xuan Li, Mathieu Coudert, Juan P. Frías

Diabetes Obesity and Metabolism

Abstract

In real-world clinical practice, glycaemic outcomes 6 months after treatment advancement from BI are similar for people with T2D using iGlarLixi versus BI + RAI, with iGlarLixi leading to less weight gain.

References

	Year	Citations
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus New England Journal of Medicine	1993	24.5K
Real-World Evidence — What Is It and What Can It Tell Us? Rachel E. Sherman, Steven A. Anderson, Gerald J. Dal Pan, New England Journal of Medicine Healthcare Monitoring SystemsEngineeringEhr SystemsReal-world EvidenceInformation Forensics	2016	1.9K
9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Medical Care in Diabetes—2022</i> Diabetes Care	2021	1.5K
Diabetes in Older Adults M. Sue Kirkman, Vanessa Jones Briscoe, Nathaniel G. Clark, Diabetes Care Geriatric PsychiatryAgingGeriatric MedicineEpidemiology Of AgingDiabetes Epidemiology	2012	1.2K
Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes Rury R. Holman, Kerensa Thorne, Andrew Farmer, New England Journal of Medicine	2007	707
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial Vanita R. Aroda, Julio Rosenstock, Carol Wysham, Diabetes Care	2016	245
BRIEF REPORT: The burden of diabetes therapy Sandeep Vijan, Rodney A. Hayward, David L. Ronis, Journal of General Internal Medicine Diabetes ManagementHealth PolicyBrief ReportDiabetesDiabetes Mellitus	2005	201
Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial Liana K. Billings, Ankur Doshi, D. Gouet, Diabetes Care	2018	179
Self‐reported non‐severe hypoglycaemic events in Europe C. G. Östenson, Petronella Geelhoed-Duijvestijn, Jorma Lahtela, Diabetic Medicine	2013	169
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes Ginger Smith Carls, Edward Tuttle, Ruoding Tan, Diabetes Care	2017	150

Page 1